In an investor call, Andrew Witty promised full transparency and 100% pass-through rebates for prescription drugs by 2028.

Our narrow economic moat rating for UnitedHealth Group reflects our generally narrow-moat view of the US health insurance and PBM industries that includes an unclear outlook for economic profitability ...

FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...

The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts—marked up prices at their pharmacies by hundreds or thousands ...

House Energy Chair Brett Guthrie said he hopes to revive the health legislation that was pushed out of the American Relief ...

The UnitedHealth Group is overcharging patients for necessary life-saving drugs as a result of price gouging that increases ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

Robert F. Kennedy Jr. has reportedly secured the votes needed for confirmation as Secretary of Health and Human Services (HHS).

On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...

The Pharmaceutical Care Management Association, which represents PBM's, called the FTC report baseless and "without ...

The Federal Trade Commission accuses CVS, Cigna and UnitedHealth of artificially inflating prices on specialty generic drugs ...